118 related articles for article (PubMed ID: 11549253)
21. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
[TBL] [Abstract][Full Text] [Related]
22. Normal human fibroblasts produce membrane-bound and soluble isoforms of FGFR-1.
Root LL; Shipley GD
Mol Cell Biol Res Commun; 2000 Feb; 3(2):87-97. PubMed ID: 10775505
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of fibroblast growth factor 8 in human breast cancer.
Marsh SK; Bansal GS; Zammit C; Barnard R; Coope R; Roberts-Clarke D; Gomm JJ; Coombes RC; Johnston CL
Oncogene; 1999 Jan; 18(4):1053-60. PubMed ID: 10023681
[TBL] [Abstract][Full Text] [Related]
24. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ
J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of fibroblast growth factor receptors in human pituitary adenomas.
Abbass SA; Asa SL; Ezzat S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1160-6. PubMed ID: 9100589
[TBL] [Abstract][Full Text] [Related]
26. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands.
McLeskey SW; Ding IY; Lippman ME; Kern FG
Cancer Res; 1994 Jan; 54(2):523-30. PubMed ID: 7506125
[TBL] [Abstract][Full Text] [Related]
27. Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES.
Zhang P; Greendorfer JS; Jiao J; Kelpke SC; Thompson JA
Arch Biochem Biophys; 2006 Jun; 450(1):50-62. PubMed ID: 16631103
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter.
Yu S; Zheng L; Asa SL; Ezzat S
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E490-5. PubMed ID: 12169442
[TBL] [Abstract][Full Text] [Related]
30. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
31. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors.
Wiedemann M; Trueb B
Genomics; 2000 Oct; 69(2):275-9. PubMed ID: 11031111
[TBL] [Abstract][Full Text] [Related]
33. High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF.
Crumley G; Bellot F; Kaplow JM; Schlessinger J; Jaye M; Dionne CA
Oncogene; 1991 Dec; 6(12):2255-62. PubMed ID: 1722570
[TBL] [Abstract][Full Text] [Related]
34. Activation of a transfected FGFR-1 receptor in Madin-Darby epithelial cells results in a reversible loss of epithelial properties.
Migdal M; Soker S; Yarden Y; Neufeld G
J Cell Physiol; 1995 Feb; 162(2):266-76. PubMed ID: 7529769
[TBL] [Abstract][Full Text] [Related]
35. Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations.
Lorenzi MV; Castagnino P; Chen Q; Chedid M; Miki T
Oncogene; 1997 Aug; 15(7):817-26. PubMed ID: 9266968
[TBL] [Abstract][Full Text] [Related]
36. Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells.
Sobue T; Gravely T; Hand A; Min YK; Pilbeam C; Raisz LG; Zhang X; Larocca D; Florkiewicz R; Hurley MM
J Bone Miner Res; 2002 Mar; 17(3):502-12. PubMed ID: 11874241
[TBL] [Abstract][Full Text] [Related]
37. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
Billottet C; Janji B; Thiery JP; Jouanneau J
Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus.
Johnston CL; Cox HC; Gomm JJ; Coombes RC
J Biol Chem; 1995 Dec; 270(51):30643-50. PubMed ID: 8530501
[TBL] [Abstract][Full Text] [Related]
39. Effect of mutation of cytoplasmic receptor domain and of genistein on transport of acidic fibroblast growth factor into cells.
Muñoz R; Klingenberg O; Wiedłocha A; Rapak A; Falnes PO; Olsnes S
Oncogene; 1997 Jul; 15(5):525-36. PubMed ID: 9247306
[TBL] [Abstract][Full Text] [Related]
40. A soluble form of K-sam/FGFR2 protein in the culture medium of human gastric cancer cells.
Kishi T; Yoshida T; Terada M
Biochem Biophys Res Commun; 1994 Aug; 202(3):1387-94. PubMed ID: 8060318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
